LifeVantage Corporation (LFVN)
Stock analysis · NASDAQ · Consumer Defensive · Packaged Foods
LifeVantage Corporation (LFVN) is a publicly traded company in the Consumer Defensive sector. Latest price: $5.88. Market cap $74.03M. Trailing PE 14.70. Dividend yield 3.23%. Sign in to Stocks360 for full DCF valuation, fundamentals, technicals, and AI-driven analysis.
Get full analysis → Short-Term Analysis →1-Year Price
Earnings
Proprietary Signals
About LifeVantage Corporation
LifeVantage Corporation (LFVN) specializes in the development, manufacture, and distribution of a diverse portfolio of health, wellness, and personal care products. Its offerings encompass nutrigenomic activators (designed to influence genetic expression), a broad array of dietary supplements, cognitive enhancers (nootropics), gut health support (pre- and pro-biotics), weight management solutions, and various personal care items spanning skin care, hair care, bath and body, and targeted relief. The company's product lineup features well-known brands such as Protandim, a series of scientifically validated dietary supplements. Specific examples include LifeVantage Omega+, a blend of DHA/EPA Omega-3s, Omega-7s, and Vitamin D3; LifeVantage ProBio, designed for digestive wellness; the PhysIQ brand for weight management; Petandim, tailored to reduce oxidative stress in dogs; and Axio energy drink mixes. Under the TrueScience brand, LifeVantage also provides anti-aging skincare (e.g., facial cleansers, perfecting lotions, eye serums, creams), hair care solutions (e.g., invigorating shampoos, nourishing conditioners, scalp serums), and an assortment of bath and body products (e.g., body l…
Valuation
| P/E (TTM) | 14.70× |
|---|---|
| P/S (TTM) | 0.41× |
| P/B | 2.19× |
| P/FCF (TTM) | 11.10× |
| EV / EBITDA | 7.80× |
| EV / Sales | 0.38× |
| Earnings Yield | 6.88% |
| Free Cash Flow Yield | 9.01% |
| Dividend Yield | 3.23% |
Fundamentals
| Enterprise Value | $68.97M |
|---|---|
| Revenue (TTM) | $182.59M |
| Net Income (TTM) | $5.09M |
| Free Cash Flow (TTM) | $6.67M |
| Net Debt | -$5.05M |
| Working Capital | $18.07M |
| Gross Margin | 77.56% |
| Operating Margin | 3.34% |
| Net Margin | 2.78% |
| Return on Equity | 15.25% |
| Return on Invested Capital | 11.64% |
Peers
Recent News
- New LifeVantage Research Explores How Protandim® Nrf2 Supports Cellular Defense Against Five Modern Environmental Toxins*
- Lifevantage (NASDAQ:LFVN) Stock Breaks Above 200 Day Moving Average – What’s Next?
- LifeVantage to Announce First Quarter Fiscal Year 2027 Results on November 9, 2026
- New Strong Sell Stocks for October 19th
- LifeVantage Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Related
Browse more tickers: sitemap